- Report
- June 2025
- 250 Pages
India
From €2484EUR$2,789USD£2,153GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3445EUR$3,869USD£2,986GBP
- Report
- February 2024
- 160 Pages
Global
From €4425EUR$4,969USD£3,835GBP
- Report
- November 2023
- 140 Pages
Global
From €3205EUR$3,599USD£2,778GBP
- Report
- June 2023
- 140 Pages
Global
From €4407EUR$4,949USD£3,820GBP
- Report
- April 2023
- 160 Pages
Global
From €4407EUR$4,949USD£3,820GBP
- Report
- February 2024
- 234 Pages
Global
€4448EUR$4,995USD£3,855GBP
- Report
- January 2024
- 306 Pages
Global
€4448EUR$4,995USD£3,855GBP
- Report
- December 2023
- 231 Pages
Global
€4448EUR$4,995USD£3,855GBP
- Report
- May 2022
- 41 Pages
Global
From €2226EUR$2,500USD£1,929GBP
- Report
- August 2023
- 51 Pages
India
From €534EUR$600USD£463GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4363EUR$4,900USD£3,782GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4363EUR$4,900USD£3,782GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4363EUR$4,900USD£3,782GBP
- Report
- August 2023
- 300 Pages
Europe
From €4363EUR$4,900USD£3,782GBP
- Report
- August 2023
- 1350 Pages
Global
From €7926EUR$8,900USD£6,869GBP
- Report
- August 2023
- 51 Pages
Argentina
From €534EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
South Korea
From €534EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
South Africa
From €534EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Australia
From €534EUR$600USD£463GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more